News
TURKU, FI / ACCESS Newswire / June 5, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN)(AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focused on developing novel ...
Detailed information about the transaction is given hereunder. Transaction notification under Article 19 of EU Market Abuse ...
Rows of tanks filled with liquid nitrogen sit in temperature-controlled chambers at Sydney's Taronga zoo, cradling parts of ...
Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company developing novel immunotherapies, has, as announced earlier today on 3 June 2025, approved the ...
Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First Tranche Bonds ...
TURKU, FI / ACCESS Newswire / June 2, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Favorable response rates and survival data in high/very high-risk frontline and r/r MDS support advancement ...
From sound to storage and control, these USB gadgets can seriously level up your PC gaming setup using the port you already ...
Nearly a decade ago, New Orleans officials hailed their new jail as a harbinger of change.
TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in hig ...
TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results